International: +1-347-960-6455

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

Please fill in the below details and our representative will shortly contact you: